Back
Halozyme Therapeutics Stock Price Chart
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Buy
59
HALO
Halozyme Therapeutics
Last Price:
$53.75
Seasonality Move:
4.55%
7 Day Trial
ALL ACCESS PASS
$
7
The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing slight selling pressure.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.47 | Sell |
| 20-day SMA: | 53.96 | Buy |
| 50-day SMA: | 58.21 | Sell |
| 200-day SMA: | 56.28 | Sell |
| 8-day EMA: | 54.28 | Buy |
| 20-day EMA: | 55.2 | Sell |
| 50-day EMA: | 57.01 | Sell |
| 200-day EMA: | 55.24 | Sell |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.24 | Sell |
| Relative Strength Index (14 RSI): | 45.65 | Sell |
| Chaikin Money Flow: | -304609 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.47 - 61.77) | Sell |
| Bollinger Bands (100): | (54.46 - 62.44) | Sell |
Halozyme Therapeutics Technical Analysis
| May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 54.38 while HALO 8-day simple moving average is 54.47, which is a Sell signal.
-
The stock price of HALO is 54.38 while Halozyme Therapeutics 20-day SMA is 53.96, which makes it a Buy.
-
Halozyme Therapeutics 50-day simple moving average is 58.21 while HALO share price is 54.38, making it a Sell technically.
-
HALO stock price is 54.38 and Halozyme Therapeutics 200-day simple moving average is 56.28, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
59
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a BuyThe current Halozyme Therapeutics [HALO] share price is $54.38. The Score for HALO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
6.7B
Price in USD:
54.38
Share Volume:
1.6M
Halozyme Therapeutics 52-Week Range
52-Week High:
70.51
52-Week Low:
42.01
Buy
59
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?The Halozyme Therapeutics stock price is 54.38 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 54.38 while HALO 8-day exponential moving average is 54.28, which is a Buy signal.
-
The stock price of HALO is 54.38 while Halozyme Therapeutics 20-day EMA is 55.20, which makes it a Sell.
-
Halozyme Therapeutics 50-day exponential moving average is 57.01 while HALO share price is 54.38, making it a Sell technically.
-
HALO stock price is 54.38 and Halozyme Therapeutics 200-day simple moving average is 55.24, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is -1.24, suggesting Halozyme Therapeutics is a Sell
-
Halozyme Therapeutics Relative Strength Index (RSI) is 45.65, which suggest Halozyme Therapeutics is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics is (50.47 - 61.77), which suggest Halozyme Therapeutics is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics is (54.46 - 62.44), which suggest Halozyme Therapeutics is a Sell
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.